e-Drug3D

939

TIGECYCLINE


INN
TIGECYCLINE

cas 220620-09-7
CLASS

ANTIINFECTIVES
ANTIBACTERIAL
TETRACYCLINE

ROUTE (list)

INTRAVENOUS

ATC code

J01AA12

PK parameters

VD 639 LITER
Cl 23.8 LITER / HOUR
PPB 80 PERCENT
t1/2 42.4 HOUR

Target

TARGET 30S RIBOSOMAL PROTEIN

DrugCentral

Unknown

Download SDF file N-[(5aR,6aS,7S,9Z,10aS)-9-(amino-hydroxymethylidene)-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide

Formula:
C29H39N5O8

Calculated chemical properties:

MW 585.65
NB_atoms 42
XLogP 0.51
PSA 196.456
NB_HD 8
NB_HA 13
fsp3 0.52
Lipinski(0=no;1=yes) 0

FDA
NDA 021821 (pdf not found) INN (TIGECYCLINE) TYGACIL (PF PRISM CV) APPROVAL= AP YEAR= 2005 NEWMOLECULARENTITY
NDA 091620 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (SANDOZ) APPROVAL= AP YEAR= 2015
NDA 205645 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (FRESENIUS KABI USA) APPROVAL= AP YEAR= 2016
NDA 208744 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (ACCORD HLTHCARE INC) APPROVAL= AP YEAR= 2018 DISCONTINUED
NDA 204439 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (APOTEX) APPROVAL= AP YEAR= 2018
NDA 211158 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (AMNEAL) APPROVAL= AP YEAR= 2018
NDA 205722 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (XELLIA PHARMS APS) APPROVAL= AP YEAR= 2019 DISCONTINUED
NDA 206335 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (EUGIA PHARMA) APPROVAL= AP YEAR= 2019
NDA 214020 (pdf not found) INN (TIGECYCLINE) TIGECYCLINE (MEITHEAL) APPROVAL= AP YEAR= 2021

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL